跳至主要内容
临床试验/NCT02694367
NCT02694367已完成不适用

MAP Kinase Signaling Pathways Through ERK and p-ERK Protein in Human Placenta of Women With Recurrent Miscarriage

Assiut University1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
1
主要终点
The levels of ERK and AKT in placenta

研究概览

简要总结

The present study is based on hypotheses that some as yet unknown genetic factors may result in recurrent miscarriage (RM). Consequently, the main aim of this study was to gain new information about the underlying genetic causes of RM in the Egyptian population and to investigate the expression of ERK and p-ERK protein in human placenta and their corresponding tissue, to assess the significance of MAPK signal pathway in progression of recurrent miscarriage and PI3K-Akt Pathway.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age less than 12 weeks.
  • no uterine abnormalities (examined by ultrasonography or hysterosonogram)
  • previous history of RM, defined as two or more consecutive miscarriages

排除标准

  • Gestational age 12 weeks or more.
  • Endocrine etiology like (thyroid dysfunction, and uncontrolled diabetes mellitus).
  • Antiphospholipid syndrome, inherited thrombophilias, alloimmune causes.
  • Uterine anatomic anomalies

结局指标

主要结局

The levels of ERK and AKT in placenta

时间窗: 48 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Dr

Assiut University

研究点 (1)

Loading locations...

相似试验